Laboratory-on-a-ship: a microbiology culture media production facility in a sea container for local production in low-resource settings
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Low-income and middle-income countries (LMICs),
especially those in western sub-Saharan Africa, are hit
hardest by antimicrobial resistance1
and would benefit
most from better access to diagnostics.2
However, only
1·3% of the diagnostic laboratories in sub-Saharan
Africa currently have the capability to perform clinical
bacteriology.3
Although used globally, microbiology
culture media play a more substantial role in LMICs,
which have less access to new-generation diagnostics.
The importance of culture media was reinforced by
WHO, who in their model list of essential in-vitro
diagnostics called for bacterial culture to be included in
first-level referral hospitals in LMICs.4,5
Due to the scarcity of local companies and supply chain
issues, ready-to-use, quality-assured culture media are
either very costly or outright unavailable in LMICs.6
This
unavailability of culture media highlights the need for
local production of high-quality products at affordable
prices. However, culture media production is a
demanding and complex task. Laboratories in LMICs face
additional challenges because of harsh environments
(heat, dust, and humidity), faulty infrastructure (poor
access to clean water and uninterrupted power supply),
and ill-maintained equipment.4,7 These laboratories
are rarely suited or sufficiently maintained to produce
culture media to international quality standards.8
The European & Developing Countries Clinical Trials
Partnership (EDCTP) 2-funded SIMBLE project aspires
to improve access to bloodstream infection diagnostics
tailored to low-resource settings. SIMBLE consortium
partners from Benin, Belgium, and Spain combined
biomedical and technical engineering in a public–private
partnership. To strengthen and scale up local production
of quality-assured culture media, we developed a
dedicated culture media production facility (appendix
p 1). The facility was manufactured in Spain and
installed in Benin, a west African country with a humid
tropical climate and a large seaport.
The preparation and design process took 6 months,
with multiple site visits to the Spanish partner to discuss
facility design and construction, equipment, and quality
management. We refurbished a sea container into a
cleanroom-like facility to physically separate culture
media production from existing laboratories, and to
ensure a stable environment (temperature, cleanliness,
and waste management). The container was equipped
with commercially available devices, including a water
treatment system, laminar flow, autoclave, media
preparator, and automatic plate-filling machine. We also
installed custom-made equipment for filling and capping
home-made blood culture bottles. Special attention was
paid to maintenance and sustainability; for example, by
choosing equipment that uses compressed air instead
of electricity, which is maintenance-friendly and not
dependent on a constant power supply.
In September, 2022, after a 6-month construction
phase in Spain and a 3-week overseas journey by cargo
ship, the Beninese team coordinated the customs
clearance and installation of the container in Cotonou,
Benin. Infrastructure, equipment maintenance, and media
production training was given with the train-the-trainer
model to enable trainees to instruct future maintenance
staff and users. The official language of Benin is French,
as such user manuals, equipment menus, and operating
procedures were written in French. Development of the
quality management system is ongoing and a roadmap
for future International Organization for Standardization
13485 certification has been prepared.
The current production capacity of the facility is
500 petri dishes and 250 blood culture bottles per batch,
with the possibility of producing multiple batches per
day. Local production can be done at a lower cost than
importing culture media from high-income countries.
For example, according to our calculations, a blood
culture bottle can be produced at 25% of the price of
the commercially available European product. Upscaling
production can reduce costs and increase the crucial
volume of available clinical bacteriology diagnostics.
Due to the shorter time from manufacturing to usage,
the user can benefit from a longer shelf life. We are
currently piloting production of solid culture media
for clinical bacteriology and blood culture bottles for
For more on the SIMBLE project
see https://www.itg.be/e/simble
See Online for appendix
Published Online
March 9, 2023
https://doi.org/10.1016/
S2666-5247(23)00070-8
Comment
e385 www.thelancet.com/microbe Vol 4 June 2023
the SIMBLE project. For this project, products will be
packaged and transported to the other study sites
(Boko, Benin and Ouagadougou, Burkina Faso). In
the future, we plan to also supply other Beninese
laboratories within a microbiology surveillance network
with quality-assured products. To this end, shelf life and
transport stability will be validated, and a sustainable
long-term business plan will be developed.
To our knowledge, this is the first dedicated
microbiology culture media production facility to be
installed in an LMIC. The Beninese team has taken over
ownership of the laboratory, and implementation
and expansion of services to other countries is being
explored. Upscaling quality-assured local production in
LMICs will increase access to affordable diagnostics and
improve the standard of care in these settings.
